Efficacy of Early Rhythm Control in AF With TR Patients
Status: Recruiting
Location: See location...
Intervention Type: Other, Procedure, Drug
Study Type: Observational
SUMMARY
Atrial fibrillation is frequently accompanied by tricuspid regurgitation and may contribute to right atrial and tricuspid annular remodeling, leading to progression of tricuspid regurgitation and adverse clinical outcomes. However, whether early rhythm control improves prognosis in patients with atrial fibrillation and tricuspid regurgitation remains unclear. This study will compare early rhythm control with usual care in these patients, using a composite outcome of cardiac death, heart failure admission, stroke, and tricuspid valve surgery.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• Patients with concomitant atrial fibrillation and tricuspid regurgitation.
Locations
Other Locations
Republic of Korea
Samsung Medical Center
RECRUITING
Seoul
Contact Information
Primary
Ju Youn Kim, Ph.D
kzzoo921@gmail.com
82+ 10-5482-7307
Time Frame
Start Date: 2026-02-18
Estimated Completion Date: 2027-02-28
Participants
Target number of participants: 5800
Treatments
early rhythm control group
Patients who received rhythm control therapy(include catheter ablation, cardioversion, anti-arrhythmic drugs) within 2 years of new-onset atrial fibrillation
Usual care group
Patients who received usual care include rate control therapy without early rhythm control intervention within 2 years of new-onset atrial fibrillation
Related Therapeutic Areas
Sponsors
Leads: Samsung Medical Center